Sivia Capital Partners LLC Takes $306,000 Position in Bath & Body Works, Inc. $BBWI

Key Points

• Sivia Capital Partners LLC made a new investment of $306,000 in Bath & Body Works by acquiring 10,206 shares in the second quarter.
• Bath & Body Works has a 52-week low of $24.94 and a 52-week high of $41.87, currently opening at $26.30 with a market cap of $5.42 billion.
• The company recently reported earnings of $0.37 per share, meeting expectations, with a quarterly revenue of $1.55 billion, a slight decline from the previous year.

Sivia Capital Partners LLC acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 10,206 shares of the company's stock, valued at approximately $306,000.

Several other institutional investors and hedge funds have also bought and sold shares of BBWI. Cetera Investment Advisers lifted its stake in Bath & Body Works by 18.4% during the 4th quarter. Cetera Investment Advisers now owns 24,877 shares of the company's stock valued at $964,000 after acquiring an additional 3,858 shares during the period. Nuveen Asset Management LLC increased its holdings in shares of Bath & Body Works by 3.7% during the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock valued at $29,628,000 after purchasing an additional 27,136 shares in the last quarter. Nomura Holdings Inc. purchased a new position in shares of Bath & Body Works during the 4th quarter valued at approximately $226,000. State of Wyoming increased its holdings in shares of Bath & Body Works by 406.9% during the 4th quarter. State of Wyoming now owns 7,269 shares of the company's stock valued at $282,000 after purchasing an additional 5,835 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new position in shares of Bath & Body Works during the 4th quarter valued at approximately $6,822,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Down 4.5%

NYSE BBWI traded down $1.18 during trading hours on Friday, reaching $25.11. The company had a trading volume of 10,541,740 shares, compared to its average volume of 7,282,604. The stock has a 50-day moving average of $29.58 and a 200 day moving average of $29.77. Bath & Body Works, Inc. has a 1-year low of $24.93 and a 1-year high of $41.87. The stock has a market capitalization of $5.18 billion, a P/E ratio of 7.45, a price-to-earnings-growth ratio of 0.86 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.37. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business's revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.2%. Bath & Body Works's dividend payout ratio is 23.74%.

Analyst Ratings Changes

Several research firms have recently weighed in on BBWI. JPMorgan Chase & Co. lifted their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Telsey Advisory Group reaffirmed an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a report on Thursday, August 28th. Wall Street Zen lowered shares of Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. UBS Group cut their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a report on Friday, August 29th. Finally, Citigroup cut their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday, August 19th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Bath & Body Works currently has a consensus rating of "Moderate Buy" and an average target price of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.